Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Xerostomia

fluorodeoxyglucose f18 has been researched along with Xerostomia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
de Vette, SPM; Langendijk, JA; Li, Y; Noordzij, W; Sijtsema, NM; Steenbakkers, RJHM; Van den Bosch, L; van Dijk, LV; Zhang, F1
Chlap, P; Fowler, A; Jameson, MG; Keall, P; Lee, MT; Lin, P; Moses, D; Trada, Y1
Campbell, F; Crosbie, R; Easton, F; Grose, D; James, A; Lamb, C; McLoone, P; Paterson, C; Poon, WY; Rizwanullah, M; Schipani, S; Thomson, M; Wilson, C1
Boellaard, R; Brouwer, CL; Burgerhof, JGM; Langendijk, JA; Noordzij, W; Sijtsema, NM; Steenbakkers, RJHM; van Dijk, LV1
Cannon, B; Dong, L; Schwartz, DL1

Other Studies

5 other study(ies) available for fluorodeoxyglucose f18 and Xerostomia

ArticleYear
Validation of the
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2023, Volume: 180

    Topics: Biomarkers; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Parotid Gland; Positron-Emission Tomography; Xerostomia

2023
Mid-treatment 18F-FDG PET imaging changes in parotid gland correlates to radiation-induced xerostomia.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2023, Volume: 186

    Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Parotid Gland; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiation Injuries; Radiotherapy Dosage; Xerostomia

2023
Comparative cohort study of volumetric modulated arc therapy for squamous cell cancer of unknown primary in the head and neck-Involved neck only versus mucosal irradiation.
    Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, 2020, Volume: 45, Issue:6

    Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mucositis; Neoplasms, Unknown Primary; Organs at Risk; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Xerostomia

2020
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2018, Volume: 126, Issue:1

    Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Logistic Models; Male; Middle Aged; Parotid Gland; Positron-Emission Tomography; Predictive Value of Tests; Radiation Injuries; Xerostomia; Young Adult

2018
Metabolic imaging biomarkers of postradiotherapy xerostomia.
    International journal of radiation oncology, biology, physics, 2012, Aug-01, Volume: 83, Issue:5

    Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Organs at Risk; Oropharyngeal Neoplasms; Parotid Gland; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiation Injuries; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed; Xerostomia

2012